Cytogenetic and cDNA microarray expression analysis of MCF10 human breast cancer progression cell lines

Cancer Research

Volumn 69, Issue 14, 2009, Pages 5946-5953

  Marella, Narasimharao V ^a,c   Malyavantham, Kishore S ^a,d   Wang, Jianmin ^b   Matsui, Sei Ichi ^b   Liang, Ping ^b,e   Berezney, Ronald ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c CANCER GENETICS INC   (United States)

^d IMMCO Diagnostics Inc   (United States)

^e BROCK UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOSS; GENETIC GAIN; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SPECTRAL KARYOTYPING; UPREGULATION;

BREAST; BREAST NEOPLASMS; CELL LINE; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; DISEASE PROGRESSION; DOWN-REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SPECTRAL KARYOTYPING; UP-REGULATION;

EID: 67651007228     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-0420     Document Type: Article

References (50)

1. Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 2004;6:229-39.
2. Ellsworth RE, Vertrees A, Love B, Hooke JA, Ellsworth DL, Shriver CD. Chromosomal alterations associated with the transition from in situ to invasive breast cancer. Ann Surg Oncol 2008;15:2519-25.
3. Reis-Filho JS, Savage K, Lambros MB, et al. Cyclin D1 protein overexpression andC CND1 amplification in breast carcinomas: an immunohistochemical andchromogenic in situ hybridisation analysis. Mod Pathol 2006;19:999-1009.
4. Teng LS, Zheng Y, Wang HH. BRCA1/2 associated hereditary breast cancer. J Zhejiang Univ Sci B 2008;9:85-9.
5. Pauley RJ, Soule HD, Tait L, et al. The MCF10 family of spontaneously immortalizedhuman breast epithelial cell lines: models of neoplastic progression. Eur J Cancer Prev 1993;2:67-76.
6. Soule HD, Maloney TM, Wolman SR, et al. Isolation andcharacterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 1990;50:6075-86.
7. Basolo F, Elliott J, Tait L, et al. Transformation of human breast epithelial cells by c-Ha-ras oncogene. Mol Carcinog 1991;4:25-35.
8. Dawson PJ, Wolman SR, Tait L, Heppner GH, Miller FR. MCF10AT: a model for the evolution of cancer from proliferative breast disease. Am J Pathol 1996;148:313-9.
9. Santner SJ, Dawson PJ, Tait L, et al. Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. Breast Cancer Res Treat 2001;65:101-10.
10. Macville M, Veldman T, Padilla-Nash H, et al. Spectral karyotyping, a 24-colour FISH technique for the identification of chromosomal rearrangements. Histochem Cell Biol 1997;108:299-305.
11. Goodison S, Viars C, Urquidi V. Molecular cytogenetic analysis of a human breast metastasis model: identification of phenotype-specific chromosomal rearrangements. Cancer Genet Cytogenet 2005;156:37-48.
12. Kallioniemi A, Kallioniemi OP, Sudar D, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solidtumors. Science 1992;258:818-21.
13. Jonsson G, Staaf J, Olsson E, et al. High-resolution genomic profiles of breast cancer cell lines assessedby tiling BAC array comparative genomic hybridization. Genes Chromosomes Cancer 2007;46:543-58.
14. DeRisi J, PenlandL, Brown PO, et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 1996;14:457-60.
15. Nuyten DS, van de Vijver MJ. Using microarray analysis as a prognostic andpred ictive tool in oncology: focus on breast cancer andnormal tissue toxicity. Semin Radiat Oncol 2008;18:105-14.
16. Nowak NJ, Snijders AM, Conroy JM, Albertson DG. The BAC resource: tools for array CGH and FISH. Curr Protoc Hum Genet 2005;Chapter 4:Unit 4 13.
17. Nowak NJ, Gaile D, Conroy JM, et al. Genome-wide aberrations in pancreatic adenocarcinoma. Cancer Genet Cytogenet 2005;161:36-50.
18. Cowell JK, Wang YD, HeadK, Conroy J, McQuaid D, Nowak NJ. Identification and characterisation of constitutional chromosome abnormalities using arrays of bacterial artificial chromosomes. Br J Cancer 2004;90:860-5.
19. Olshen AB, Venkatraman ES, Lucito R, Wigler M. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 2004;5:557-72.
20. Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004;3:Article3.
21. Beissbarth T, Speed TP. GOstat: find statistically overrepresented gene ontologies within a group of genes. Bioinformatics 2004;20:1464-5.
22. Squires J, Berry MJ. Selenium, selenoproteins, and cancer. Hawaii Med J 2006;65:239-40.
23. Baliga MS, Wang H, Zhuo P, Schwartz JL, Diamond AM. Selenium and GPx -1 overexpression protect mammalian cells against UV-induced DNA damage. Biol Trace Elem Res 2007;115:227-42.
24. Goldoni S, Seidler DG, Heath J, et al. An antimetastatic role for decorin in breast cancer. Am J Pathol 2008;173:844-55.
25. Tseleni-Balafouta S, Gakiopoulou H, Fanourakis G, et al. Fibrillin expression andlocaliza tion in various types of carcinomas of the thyroidgland . Mod Pathol 2006;19:695-700.
26. Wright RM, McManaman JL, Repine JE. Alcohol-induced breast cancer: a proposed mechanism. Free Radic Biol Med 1999;26:348-54.
27. Wang D, Dubois RN. Prostaglandins and cancer. Gut 2006;55:115-22.
28. Hayes AJ, Huang WQ, Yu J, et al. Expression and function of angiopoietin-1 in breast cancer. Br J Cancer 2000;83:1154-60.
29. Nollet F, Berx G, van Roy F. The role of the Ecadherin/ catenin adhesion complex in the development andprogression of cancer. Mol Cell Biol Res Commun 1999;2:77-85.
30. Pietas A, Schluns K, Marenholz I, Schafer BW, Heizmann CW, Petersen I.Molecular cloning andchar acterization of the human S100A14 gene encoding a novel member of the S100 family. Genomics 2002;79:513-22.
31. Greco S, Elia MG, Muscella A, Romano S, Storelli C, Marsigliante S. Bradykinin stimulates cell proliferation through an extracellular-regulated kinase 1 and 2-dependent mechanism in breast cancer cells in primary culture. J Endocrinol 2005;186:291-301.
32. Cowell JK, LaDuca J, Rossi MR, Burkhardt T, Nowak NJ, Matsui S. Molecular characterization of the t(3;9) associated with immortalization in the MCF10A cell line. Cancer Genet Cytogenet 2005;163:23-9.
33. Worsham MJ, Pals G, Schouten JP, et al. High-resolution mapping of molecular events associated with immortalization, transformation, and progression to breast cancer in the MCF10 model. Breast Cancer Res Treat 2006;96:177-86.
34. Christensen L. The distribution of fibronectin, laminin andtetran ectin in human breast cancer with special attention to the extracellular matrix. APMIS Suppl 1992;26:1-39.
35. Mendes O, Kim HT, Lungu G, Stoica G. MMP2 role in breast cancer brain metastasis development and its regulation by TIMP2 and ERK1/2. Clin Exp Metastasis 2007;24:341-51.
36. Moasser MM. The oncogene HER2: its signaling and transforming functions andits role in human cancer pathogenesis. Oncogene 2007;26:6469-87.
37. Maehama T. PTEN: its deregulation and tumorigenesis. Biol Pharm Bull 2007;30:1624-7.
38. Balasubramanian SP, Azmy IA, Higham SE, et al. Interleukin gene polymorphisms andbreas t cancer: a case control study and systematic literature review. BMC Cancer 2006;6:188.
39. Al-Rawi MA, Mansel RE, Jiang WG. Interleukin-7 (IL-7) and IL-7 receptor (IL-7R) signalling complex in human solid tumours. Histol Histopathol 2003;18:911-23.
40. Anamthawat-Jonsson K, Eyfjord JE, Ogmundsdottir HM, Petursdottir I, Steinarsdottir M. Instability of chromosomes 1, 3, 16, and1 7 in primary breast carcinomas inferred by fluorescence in situ hybridization. Cancer Genet Cytogenet 1996;88:1-7.
41. Mark HF, Taylor W, Afify A, et al. Stage I andstage II infiltrating ductal carcinoma of the breast analyzed for chromosome 8 copy number using fluorescent in situ hybridization. Pathobiology 1997;65:184-9.
42. Hodgson JG, Chin K, Collins C, Gray JW. Genome amplification of chromosome 20 in breast cancer. Breast Cancer Res Treat 2003;78:337-45.
43. Andersen CL, Monni O, Wagner U, et al. High-throughput copy number analysis of 17q23 in 3520 tissue specimens by fluorescence in situ hybridization to tissue microarrays. Am J Pathol 2002;161:73-9.
44. Johannsdottir HK, Jonsson G, Johannesdottir G, et al. Chromosome 5 imbalance mapping in breast tumors from BRCA1 and BRCA 2 mutation carriers and sporadic breast tumors. Int J Cancer 2006;119:1052-60.
45. Forozan F, Mahlamaki EH, Monni O, et al. Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. Cancer Res 2000;60:4519-25.
46. Yang ZQ, Streicher KL, Ray ME, Abrams J, Ethier SP. Multiple interacting oncogenes on the 8p11-p12 amplicon in human breast cancer. Cancer Res 2006;66:11632-43.
47. Jiang M, Li M, Fu X, et al. Simultaneously d etection of genomic andexpress ion alterations in prostate cancer using cDNA microarray. Prostate 2008;68:1496-509.
48. Chin K, de Solorzano CO, Knowles D, et al. In situ analyses of genome instability in breast cancer. Nat Genet 2004;36:984-8.
49. Hampton OA, Den Hollander P, Miller CA, et al. A sequence-level map of chromosomal breakpoints in the MCF-7 breast cancer cell line yields insights into the evolution of a cancer genome. Genome Res 2009;19:167-77. Epub 2008 Dec 3.
50. Clark SJ. Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis. Hum Mol Genet 2007;16:R88-R95.